Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer-Reference-Cited by-同舟云学术

Molecular Grade (FGFR3/MIB-1) and EORTC Risk Scores Are Predictive in Primary Non–Muscle-Invasive Bladder Cancer

Published:2010-09 Issue:3 Volume:58 Page:433-441
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

van Rhijn Bas W.G.,Zuiverloon Tahlita C.M.,Vis André N.,Radvanyi François,van Leenders Geert J.L.H.,Ooms Bert C.M.,Kirkels Wim J.,Lockwood Gina A.,Boevé Egbert R.,Jöbsis Adriaan C.,Zwarthoff Ellen C.,van der Kwast Theo H.

Publisher

Elsevier BV

Subject

Urology

Reference23 articles.

1. Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome;van Rhijn;J Clin Oncol,2003

2. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

3. EAU Guidelines on non-muscle-invasive urothelial carcinoma of the bladder;Babjuk;Eur Urol,2008

4. Recurrence and progression of disease in non–muscle-invasive bladder cancer: from epidemiology to treatment strategy;van Rhijn;Eur Urol,2009

5. Bladder cancer: epidemiology, staging and grading, and diagnosis;Kirkali;Urology,2005

Cited by 165 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neue Therapieansätze beim nicht-muskelinvasiven Urothelkarzinom der Harnblase – Ist der Organerhalt auch nach BCG (Bacillus Calmette-Guérin) möglich?;Die Urologie;2024-08-23

2. Molecular biomarkers of progression in non-muscle-invasive bladder cancer — beyond conventional risk stratification;Nature Reviews Urology;2024-08-02

3. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

4. Development and Validation of Prognostic Nomogram to Predict Overall Survival for Older Patients Who Age 75 Years or Older With Urothelial Carcinoma of Bladder;JU Open Plus;2024-05

5. Prediction for recurrent non-muscle invasive bladder cancer;Cancer Biomarkers;2023-11-20